Zdrowie i gospodarka · 05/12/2022
FDA Renewal of Oncologic Drugs Advisory Committee
The FDA is renewing the Oncologic Drugs Advisory Committee for an additional 2 years, with the new charter set to expire on September 1, 2024.
Zdrowie i gospodarka · 05/12/2022
The FDA is renewing the Oncologic Drugs Advisory Committee for an additional 2 years, with the new charter set to expire on September 1, 2024.